Komori
Ono Pharmaceutical (4528) · FactAmericas, Asia and Europe up; Japan down

Growth in sales in the Americas and Asia and decline in sales in Japan and Europe

First written in FY2020-Q3. . Latest entry: FY2026.

21entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2020-Q3 – FY20262020: 420202021: 320212022: 420222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Regional sales comparison: revenue growth in the Americas and Asia versus declines in Japan and EuropeA theme 1 companies write about · 0 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026Americas, Asia and Europe up; Japan downAnnual report

    「Revenue by region for the fiscal year was ¥287,085 million in Japan, ¥197,061 million in the United States, ¥17,719 million in Asia, ¥12,324 million in Europe and ¥1,595 million in Other.」

    Revenue declined in Japan year on year, while it increased in the United States, Asia, Europe and other regions.
  2. FY2026-H1United States, Asia and Europe up; Japan down in the interim periodAnnual report

    「Revenue by region for the current interim consolidated period was Japan ¥148,833 million, the United States ¥93,514 million, Asia ¥8,906 million, Europe ¥5,124 million and Other ¥759 million.」

    While revenue declined year on year in Japan, it increased in the United States, Asia, Europe and Other regions. United States revenue includes the increased full-year contribution from Deciphera products and other factors.
  3. FY2025United States and Asia up; Japan and Europe down for the full yearAnnual report

    「Revenue by region for the consolidated fiscal year was Japan ¥295,247 million, the United States ¥167,048 million, Asia ¥16,343 million, Europe ¥7,503 million and Other ¥729 million.」

    While revenue declined year on year in Japan and Europe, it increased in the United States, Asia and Other. Europe was affected by the reversal of the prior year's one-time settlement payment related to patent litigation.
  4. FY2025-H1Japan and Europe down; United States and Asia up in the interim periodAnnual report

    「Japan 155,370 150,718 / United States 76,971 79,170 / Asia 6,961 7,451 / Europe 19,411 2,824 / Other - 178」

    While revenue declined year on year in Japan and Europe, it increased in the United States and Asia. European revenue was affected by the reversal of the one-time settlement payment related to patent litigation recorded in the prior-year period.
  5. FY2024Revenue increased in all regions for the full year; sharp increase in European revenueAnnual report

    「Revenue by region for the consolidated fiscal year was Japan ¥308,229 million, the Americas ¥158,933 million, Europe ¥21,926 million and Asia ¥13,585 million.」

    Full-year revenue increased in all regions, with Europe increasing from ¥4,616 million to ¥21,926 million, including the impact of a one-time settlement payment and other items related to patent litigation.
  6. FY2024-Q3Revenue increased in all regions in the third quarter; sharp increase in European revenueAnnual report

    「Revenue by region for the nine months ended the current third quarter was Japan ¥240,236 million, the Americas ¥118,649 million, Europe ¥20,643 million and Asia ¥10,376 million.」

    For the nine months ended the third quarter, revenue exceeded the prior-year period in all regions: Japan, the Americas, Europe and Asia. European revenue increased from ¥3,374 million in the prior-year period to ¥20,643 million, including a one-time settlement payment and other items related to patent litigation.
  7. FY2024-Q2Revenue increased in all regions in the first half; sharp increase in European revenueAnnual report

    「Revenue by region for the six months ended the current second quarter was Japan ¥155,370 million, the Americas ¥76,971 million, Europe ¥19,411 million and Asia ¥6,961 million.」

    In the first half, revenue exceeded the prior-year period in all regions: Japan, the Americas, Europe and Asia. European revenue increased from ¥2,157 million in the prior-year period to ¥19,411 million, including a one-time settlement payment and other items related to patent litigation.
  8. FY2024-Q1Revenue increased in all regions in the first quarterAnnual report

    「Japan 70,784 78,187 / Americas 32,266 37,143 / Asia 2,667 3,544 / Europe 1,005 1,142」

    In the current first quarter, revenue exceeded the prior-year period in all regions: Japan, the Americas, Asia and Europe.
  9. FY2023Revenue increased in all regions for the full yearAnnual report

    「Revenue by region for the consolidated fiscal year was Japan ¥288,155 million, the Americas ¥142,791 million, Asia ¥11,625 million and Europe ¥4,616 million.」

    For the fiscal year ending March 2023, revenue increased from the previous fiscal year in all regions: Japan, the Americas, Asia and Europe.
  10. FY2023-Q3Revenue increased in all regions in the third quarterAnnual report

    「Japan 183,327 220,620 / Americas 78,308 105,329 / Asia 6,375 8,599 / Europe 3,420 4,473」

    Revenue by region for the nine months ended the third quarter exceeded the prior-year period in all regions: Japan, the Americas, Asia and Europe.
  11. FY2023-Q2Revenue increased in all regions in the first halfAnnual report

    「Japan 117,631 141,934 / Americas 50,254 66,450 / Asia 4,010 5,460 / Europe 2,182 2,857」

    For the six months ended the second quarter of the fiscal year ending March 2023, revenue exceeded the prior-year period in all regions: Japan, the Americas, Asia and Europe.
  12. FY2023-Q1Revenue increased in all regions in the first quarterAnnual report

    「Japan 59,829 70,784 / Americas 24,591 31,939 / Asia 1,875 2,667 / Europe 1,068 1,332」

    In the first quarter of the fiscal year ending March 2023, revenue exceeded the prior-year period in all regions: Japan, the Americas, Asia and Europe.
  13. FY2022Revenue increased in all regions for the full yearAnnual report

    「Revenue by region for the consolidated fiscal year was Japan ¥241,971 million, the Americas ¥105,890 million, Asia ¥8,895 million and Europe ¥4,605 million.」

    For the fiscal year ending March 2022, revenue increased year on year in all regions: Japan, the Americas, Asia and Europe.
  14. FY2022-Q3Revenue increased in all regions in the third quarterAnnual report

    「Japan 163,361 183,327 / Americas 63,288 78,308 / Asia 5,813 6,375 / Europe 2,471 3,420」

    Revenue by region for the nine months ended the third quarter was Japan ¥183,327 million, the Americas ¥78,308 million, Asia ¥6,375 million and Europe ¥3,420 million, exceeding the prior-year period in all regions.
  15. FY2022-Q2Revenue increased in all regions in the first halfAnnual report

    「Japan 105,011 117,631 / Americas 41,291 50,254 / Asia 3,843 4,010 / Europe 329 2,182」

    For the six months ended the second quarter of the fiscal year ending March 2022, revenue increased year on year in all regions: Japan, the Americas, Asia and Europe.
  16. FY2022-Q1First-quarter revenue mix by regionAnnual report

    「Japan 59,829 / Americas 24,591 / Asia 1,875 / Europe 1,068」

    Revenue by region for the first quarter of the fiscal year ending March 2022 was Japan ¥59,829 million, the Americas ¥24,591 million, Asia ¥1,875 million and Europe ¥1,068 million. Year on year, revenue increased in all regions: Japan, the Americas, Asia and Europe.
  17. FY2021Japan, the Americas and Europe up; Asia slightly down for the full yearAnnual report

    「Japan 212,865 / Americas 85,566 / Asia 7,446 / Europe 3,407」

    Full-year revenue by region increased in Japan, the Americas and Europe from the previous fiscal year, while Asia declined slightly from ¥7,481 million to ¥7,446 million.
  18. FY2021-Q2First-half revenue mix by regionAnnual report

    「Japan 105,011 / Americas 41,291 / Asia 3,843 / Europe 329」

    Revenue by region for the six months ended the second quarter of the fiscal year ending March 2021 was Japan ¥105,011 million, the Americas ¥41,291 million, Asia ¥3,843 million and Europe ¥329 million. Year on year, revenue declined in Japan and Asia and increased in the Americas and Europe.
  19. FY2021-Q1First-quarter revenue mix by regionAnnual report

    「Japan 52,877 / Americas 20,042 / Asia 1,835 / Europe 159」

    Revenue by region for the current first quarter was Japan ¥52,877 million, the Americas ¥20,042 million, Asia ¥1,835 million and Europe ¥159 million. Year on year, revenue increased in Japan, the Americas and Europe and declined in Asia.
  20. FY2020Americas and Asia up; Japan and Europe down for the full yearAnnual report

    「Revenue by region for the consolidated fiscal year was Japan ¥202,866 million, the Americas ¥81,545 million, Asia ¥7,481 million and Europe ¥528 million.」

    Full-year revenue by region declined in Japan and Europe from the previous fiscal year and increased in the Americas and Asia.
  21. FY2020-Q3First statedAnnual report

    「Japan 158,569 / Americas 60,214 / Asia 6,185 / Europe 330 (¥ million)」

    Revenue by region for the nine months ended the third quarter was disclosed as Japan ¥158,569 million, the Americas ¥60,214 million, Asia ¥6,185 million and Europe ¥330 million. Year on year, revenue declined in Japan and Europe and increased in the Americas and Asia.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Ono Pharmaceutical's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Growth in sales in the Americas and Asia and decline in sales in Japan and Europe | ONO PHARMACEUTICAL CO.,LTD. (4528) | Komori